Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 81 peer-reviewed journal articles Updated
Infectious Disease

Understanding Your Melioidosis Diagnosis

At a Glance

Melioidosis is a treatable but complex bacterial infection contracted from contaminated soil or water. While it mimics other diseases like tuberculosis, it is not contagious. Successful recovery requires a two-phase antibiotic treatment lasting several months and careful management of diabetes.

If you have just been diagnosed with melioidosis, it is normal to feel overwhelmed or confused. This is a rare and complex condition that many doctors in the United States and Europe may never see in their entire careers [1][2]. You may have spent weeks or months searching for answers while your symptoms were mistaken for something else. Understanding the nature of this disease is the first step toward a successful recovery.

What is Melioidosis?

Melioidosis is an infectious disease caused by the bacterium Burkholderia pseudomallei [3]. These bacteria naturally live in soil and surface water, particularly in tropical and subtropical climates [4][5]. While it is most common in Southeast Asia and Northern Australia, it is now considered an emerging health concern in other parts of the world, including the Gulf Coast of the United States [6][7].

You likely contracted the infection through direct contact with a contaminated environment, such as:

  • Skin abrasions or cuts touching soil or water [3].
  • Inhaling dust or water droplets during heavy rains or storms [6].
  • Ingesting contaminated water [7].

Why the Diagnosis is Difficult

Melioidosis is often called “The Great Mimicker” because its symptoms are highly variable and frequently look like other diseases [8][9].

  • Mimics Tuberculosis (TB): It can cause chronic fevers, weight loss, and lung issues that are nearly identical to TB [8][10].
  • Mimics Pneumonia: It often presents as a severe lung infection, similar to standard community-acquired pneumonia [11][12].
  • Laboratory Challenges: Standard hospital lab equipment can sometimes misidentify this bacterium as a more common, less serious species [13][14].

Because it is so rare in non-endemic areas, doctors may not think to test for it unless you provide a detailed travel history or have specific risk factors [1][15].

Three Stabilizing Facts

In the midst of this new diagnosis, keep these three facts in mind to help ground your perspective:

  1. It is Treatable: While serious, melioidosis is highly treatable with a specific, two-phase antibiotic regimen [16]. Most patients require an intensive phase (intravenous antibiotics in the hospital) followed by an eradication phase (oral antibiotics at home for 3 to 6 months) [16][17].
  2. It is Not Contagious: You cannot spread melioidosis to your family, friends, or caregivers through casual contact [6][3]. It is an environmental infection, not a “person-to-person” one.
  3. Completion is Key: The long duration of treatment is necessary because the bacteria are very resilient and can “hide” in the body [18]. Finishing the entire course of medication is the most effective way to prevent the infection from returning [16][17].

The Role of Diabetes

Diabetes mellitus is the single most significant risk factor for developing melioidosis [19][20]. High blood sugar can impair the immune system’s ability to fight off this specific bacterium [21][22]. If you have diabetes, managing your blood sugar levels will be a critical part of your treatment plan to help your body heal and reduce the risk of complications [23][20].

Continue Exploring This Guide:

01

How Melioidosis Affects Your Body

Learn how melioidosis affects your body, including its four main presentations. Understand why it mimics tuberculosis and how diabetes impacts your infection.

02

Understanding Your Lab Results and Diagnosis

Learn how to read your melioidosis lab results. Understand diagnostic tests, why automated systems misidentify it, and the role of bacterial culture and PCR.

03

Your Treatment Roadmap: IV and Oral Phases

Learn about the two-phase treatment for melioidosis. Understand the intensive IV phase, the 12-week oral eradication phase, and how to manage side effects.

04

Life After the Hospital: Staying in Remission

Learn how to navigate the melioidosis eradication phase. Understand the risk of relapse versus reinfection, follow-up tests, and why diabetes management is vital.

Common questions in this guide

Is melioidosis contagious from person to person?
No, melioidosis is not contagious. You cannot spread the infection to your family, friends, or caregivers through casual contact. It is strictly an environmental infection caused by bacteria found in contaminated soil and surface water.
Why is melioidosis called 'The Great Mimicker'?
Melioidosis symptoms are highly variable and frequently resemble other common diseases. It can cause chronic fevers, weight loss, and severe lung issues that look nearly identical to tuberculosis or community-acquired pneumonia, making it challenging to diagnose accurately.
How is melioidosis treated?
Melioidosis is highly treatable using a specific, two-phase antibiotic regimen. Patients typically undergo an intensive phase with intravenous antibiotics in the hospital, followed by an eradication phase taking oral antibiotics at home for three to six months to prevent the infection from returning.
How does diabetes affect melioidosis recovery?
Diabetes is the single most significant risk factor for developing melioidosis because high blood sugar impairs the immune system's ability to fight off this specific bacterium. If you have diabetes, strict management of your blood sugar levels is a critical part of the recovery process.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was the specific evidence (culture or molecular test) used to confirm my diagnosis?
  2. 2.Is my current treatment plan following the recommended intensive (IV) and eradication (oral) phases?
  3. 3.How does my diabetes (or other risk factors) affect how we should manage this infection?
  4. 4.How will we monitor for side effects or signs that the infection is returning during the long-term oral phase?
  5. 5.Are there any specific activities involving soil or water that I should avoid during my recovery?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Whole Genome Sequencing and Comparative Genomics of the Emerging Pathogen Burkholderia pseudomallei Isolated from Two Travel-Related Infections in Hungary.

    Henczkó J, Tóth Á, Knausz M, et al.

    Pathogens (Basel, Switzerland) 2025; (14(11)) doi:10.3390/pathogens14111108.

    PMID: 41305346
  2. 2

    Multi-systemic melioidosis.

    Nagoba BS, Dhotre SV, Rayate AS, et al.

    World journal of clinical cases 2024; (12(28)):6151-6154 doi:10.12998/wjcc.v12.i28.6151.

    PMID: 39371552
  3. 3

    Burkholderia pseudomallei in soil and natural water bodies in rural Sri Lanka: A hidden threat to public health.

    Jayasinghearachchi HS, Muthugama TA, Masakorala J, et al.

    Frontiers in veterinary science 2022; (9()):1045088 doi:10.3389/fvets.2022.1045088.

    PMID: 36733425
  4. 4

    Presence of Burkholderia pseudomallei in the 'Granary of Myanmar'.

    Win TT, Su KK, Than AM, et al.

    Tropical medicine and infectious disease 2019; (4(1)) doi:10.3390/tropicalmed4010008.

    PMID: 30621177
  5. 5

    Melioidosis in South Asia (India, Nepal, Pakistan, Bhutan and Afghanistan).

    Mukhopadhyay C, Shaw T, Varghese GM, Dance DAB

    Tropical medicine and infectious disease 2018; (3(2)) doi:10.3390/tropicalmed3020051.

    PMID: 30274447
  6. 6

    The Expanding Global Footprint of Burkholderia pseudomallei and Melioidosis.

    Currie BJ, Meumann EM, Kaestli M

    The American journal of tropical medicine and hygiene 2023; (108(6)):1081-1083 doi:10.4269/ajtmh.23-0223.

    PMID: 37160279
  7. 7

    Genomic Epidemiology Links Burkholderia pseudomallei from Individual Human Cases to B. pseudomallei from Targeted Environmental Sampling in Northern Australia.

    Webb JR, Mayo M, Rachlin A, et al.

    Journal of clinical microbiology 2022; (60(3)):e0164821 doi:10.1128/JCM.01648-21.

    PMID: 35080450
  8. 8

    Pulmonary Melioidosis Masquerading As Tuberculosis: A Case Report Presenting a Rare Medical Condition From Western India.

    Gaikwad N, Makashir PA, Kelkar R, et al.

    Cureus 2025; (17(10)):e95272 doi:10.7759/cureus.95272.

    PMID: 41287745
  9. 9

    Melioidosis with a subdural collection - a case report.

    Amarasena HLP, Silva FHDS, Tilakaratna PMYI, et al.

    BMC infectious diseases 2019; (19(1)):143 doi:10.1186/s12879-019-3782-0.

    PMID: 30755178
  10. 10

    Burkholderia pseudomallei infection presenting with a lung abscess and osteomyelitis in an adult man: A case report.

    Huang L, Yang Z, Zhou XP, Wu JR

    Medicine 2018; (97(35)):e12145 doi:10.1097/MD.0000000000012145.

    PMID: 30170455
  11. 11

    Laboratory Investigations in Patients with Community Acquired Sepsis and/or Pneumonia Caused by Burkholderia pseudomallei.

    Behera B, Radhakrishnanan A, Mishra B, et al.

    The American journal of tropical medicine and hygiene 2022;.

    PMID: 35344934
  12. 12

    Melioidosis: A Neglected Cause of Community-Acquired Pneumonia.

    Virk HS, Mukhopadhyay C, Wiersinga WJ

    Seminars in respiratory and critical care medicine 2020; (41(4)):496-508 doi:10.1055/s-0040-1710570.

    PMID: 32629488
  13. 13

    Showing the limitations of available phenotypic assays to detect Burkholderia pseudomallei from clinical specimens in Nigeria.

    Orababa OQ, Adesida SA, Peters RF, et al.

    Access microbiology 2023; (5(10)) doi:10.1099/acmi.0.000604.v5.

    PMID: 37970086
  14. 14

    Comprehensive approaches for the detection of Burkholderia pseudomallei and diagnosis of melioidosis in human and environmental samples.

    Oslan SNH, Yusoff AH, Mazlan M, et al.

    Microbial pathogenesis 2022; (169()):105637 doi:10.1016/j.micpath.2022.105637.

    PMID: 35710088
  15. 15

    Travel-associated melioidosis: a narrative review.

    Norman FF, Chen LH

    Journal of travel medicine 2023; (30(3)) doi:10.1093/jtm/taad039.

    PMID: 36971472
  16. 16

    Oral eradication therapy for melioidosis: Important but not without risks.

    Sullivan RP, Ward L, Currie BJ

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2019; (80()):111-114 doi:10.1016/j.ijid.2019.01.019.

    PMID: 30659921
  17. 17

    Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast Thailand during 2015-2018 and the genomic characterization of β-lactam-resistant isolates.

    Fen SHY, Tandhavanant S, Phunpang R, et al.

    Antimicrobial agents and chemotherapy 2023; (95(5)) doi:10.1128/AAC.02230-20.

    PMID: 33593842
  18. 18

    Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei.

    Webb JR, Price EP, Currie BJ, Sarovich DS

    Antimicrobial agents and chemotherapy 2017; (61(6)) doi:10.1128/AAC.00268-17.

    PMID: 28348161
  19. 19

    Clinical Manifestations, Antimicrobial Drug Susceptibility Patterns, and Outcomes in Melioidosis Cases, India.

    Koshy M, Jagannati M, Ralph R, et al.

    Emerging infectious diseases 2019; (25(2)):316-320 doi:10.3201/eid2502.170745.

    PMID: 30666953
  20. 20

    Melioidosis as a Mystique Infection: A Study From Central India.

    Yadav V, Pawar A, Meena M, et al.

    Cureus 2023; (15(8)):e43439 doi:10.7759/cureus.43439.

    PMID: 37711937
  21. 21

    The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System.

    Daryabor G, Atashzar MR, Kabelitz D, et al.

    Frontiers in immunology 2020; (11()):1582 doi:10.3389/fimmu.2020.01582.

    PMID: 32793223
  22. 22

    The regulatory role of insulin in energy metabolism and leukocyte functions.

    Cruz-Pineda WD, Parra-Rojas I, Rodríguez-Ruíz HA, et al.

    Journal of leukocyte biology 2022; (111(1)):197-208 doi:10.1002/JLB.2RU1220-847R.

    PMID: 33724523
  23. 23

    The Epidemiology of Melioidosis and Its Association with Diabetes Mellitus: A Systematic Review and Meta-Analysis.

    Chowdhury S, Barai L, Afroze SR, et al.

    Pathogens (Basel, Switzerland) 2022; (11(2)) doi:10.3390/pathogens11020149.

    PMID: 35215093

This page provides general information about a melioidosis diagnosis for educational purposes. Always consult your infectious disease specialist or primary care physician for specific medical advice and treatment planning.

Get notified when new evidence is published on Melioidosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.